Oxidative  ||| S:0 E:10 ||| JJ
theory  ||| S:10 E:17 ||| NN
of  ||| S:17 E:20 ||| IN
atherosclerosis  ||| S:20 E:36 ||| NN
and  ||| S:36 E:40 ||| CC
antioxidants  ||| S:40 E:53 ||| JJ
Atherosclerosis  ||| S:53 E:69 ||| NNP
is  ||| S:69 E:72 ||| VBZ
a  ||| S:72 E:74 ||| DT
multifactorial  ||| S:74 E:89 ||| JJ
process  ||| S:89 E:97 ||| NN
that  ||| S:97 E:102 ||| WDT
begins  ||| S:102 E:109 ||| VBZ
early  ||| S:109 E:115 ||| RB
in  ||| S:115 E:118 ||| IN
infancy  ||| S:118 E:126 ||| NN
and  ||| S:126 E:130 ||| CC
affects  ||| S:130 E:138 ||| VBZ
all  ||| S:138 E:142 ||| PDT
the  ||| S:142 E:146 ||| DT
humans ||| S:146 E:152 ||| NNS
.  ||| S:152 E:154 ||| .
Early  ||| S:154 E:160 ||| JJ
steps  ||| S:160 E:166 ||| NNS
of  ||| S:166 E:169 ||| IN
atherogenesis  ||| S:169 E:183 ||| NN
and  ||| S:183 E:187 ||| CC
the  ||| S:187 E:191 ||| DT
evolution  ||| S:191 E:201 ||| NN
towards  ||| S:201 E:209 ||| IN
complex  ||| S:209 E:217 ||| JJ
atherosclerotic  ||| S:217 E:233 ||| JJ
plaques  ||| S:233 E:241 ||| NNS
are  ||| S:241 E:245 ||| VBP
briefly  ||| S:245 E:253 ||| RB
described ||| S:253 E:262 ||| VBN
.  ||| S:262 E:264 ||| .
After  ||| S:264 E:270 ||| IN
a  ||| S:270 E:272 ||| DT
brief  ||| S:272 E:278 ||| JJ
history  ||| S:278 E:286 ||| NN
of  ||| S:286 E:289 ||| IN
the  ||| S:289 E:293 ||| DT
' ||| S:293 E:294 ||| POS
Lipid  ||| S:294 E:300 ||| JJ
theory  ||| S:300 E:307 ||| NN
of  ||| S:307 E:310 ||| IN
atherosclerosis ||| S:310 E:325 ||| NN
' ||| S:325 E:326 ||| POS
,  ||| S:326 E:328 ||| ,
we  ||| S:328 E:331 ||| PRP
report  ||| S:331 E:338 ||| VBP
the  ||| S:338 E:342 ||| DT
most  ||| S:342 E:347 ||| RBS
prominent  ||| S:347 E:357 ||| JJ
discoveries  ||| S:357 E:369 ||| NNS
on  ||| S:369 E:372 ||| IN
lipoproteins ||| S:372 E:384 ||| NNS
,  ||| S:384 E:386 ||| ,
their  ||| S:386 E:392 ||| PRP$
receptors  ||| S:392 E:402 ||| NNS
and  ||| S:402 E:406 ||| CC
metabolism ||| S:406 E:416 ||| NN
,  ||| S:416 E:418 ||| ,
and  ||| S:418 E:422 ||| CC
their  ||| S:422 E:428 ||| PRP$
role  ||| S:428 E:433 ||| NN
in  ||| S:433 E:436 ||| IN
atherogenesis ||| S:436 E:449 ||| NN
.  ||| S:449 E:451 ||| .
The  ||| S:451 E:455 ||| DT
main  ||| S:455 E:460 ||| JJ
focus  ||| S:460 E:466 ||| NN
is  ||| S:466 E:469 ||| VBZ
the  ||| S:469 E:473 ||| DT
' ||| S:473 E:474 ||| POS
oxidative  ||| S:474 E:484 ||| JJ
theory  ||| S:484 E:491 ||| NN
of  ||| S:491 E:494 ||| IN
atherosclerosis ||| S:494 E:509 ||| NN
' ||| S:509 E:510 ||| POS
,  ||| S:510 E:512 ||| ,
with  ||| S:512 E:517 ||| IN
emphasis  ||| S:517 E:526 ||| NN
on  ||| S:526 E:529 ||| IN
free  ||| S:529 E:534 ||| JJ
radicals  ||| S:534 E:543 ||| NNS
and  ||| S:543 E:547 ||| CC
reactive  ||| S:547 E:556 ||| JJ
oxygen  ||| S:556 E:563 ||| NN
species ||| S:563 E:570 ||| NNS
,  ||| S:570 E:572 ||| ,
lipid  ||| S:572 E:578 ||| JJ
peroxidation  ||| S:578 E:591 ||| NN
and  ||| S:591 E:595 ||| CC
LDL  ||| S:595 E:599 ||| NNP
oxidation ||| S:599 E:608 ||| NN
,  ||| S:608 E:610 ||| ,
biological  ||| S:610 E:621 ||| JJ
properties  ||| S:621 E:632 ||| NNS
of  ||| S:632 E:635 ||| IN
oxidized  ||| S:635 E:644 ||| JJ
LDL  ||| S:644 E:648 ||| NNP
and  ||| S:648 E:652 ||| CC
their  ||| S:652 E:658 ||| PRP$
potential  ||| S:658 E:668 ||| JJ
role  ||| S:668 E:673 ||| NN
in  ||| S:673 E:676 ||| IN
atherogenesis ||| S:676 E:689 ||| NN
.  ||| S:689 E:691 ||| .
Then ||| S:691 E:695 ||| RB
,  ||| S:695 E:697 ||| ,
we  ||| S:697 E:700 ||| PRP
report  ||| S:700 E:707 ||| VBP
the  ||| S:707 E:711 ||| DT
properties  ||| S:711 E:722 ||| NNS
of  ||| S:722 E:725 ||| IN
antioxidants  ||| S:725 E:738 ||| NN
and  ||| S:738 E:742 ||| CC
antioxidant  ||| S:742 E:754 ||| JJ
systems  ||| S:754 E:762 ||| NNS
and  ||| S:762 E:766 ||| CC
their  ||| S:766 E:772 ||| PRP$
effects  ||| S:772 E:780 ||| NNS
in vitro ||| S:780 E:788 ||| RB
,  ||| S:788 E:790 ||| ,
on  ||| S:790 E:793 ||| IN
cultured  ||| S:793 E:802 ||| JJ
cells ||| S:802 E:807 ||| NNS
,  ||| S:807 E:809 ||| ,
in  ||| S:809 E:812 ||| IN
animal  ||| S:812 E:819 ||| JJ
models  ||| S:819 E:826 ||| NNS
and  ||| S:826 E:830 ||| CC
in  ||| S:830 E:833 ||| IN
humans ||| S:833 E:839 ||| NNS
.  ||| S:839 E:841 ||| .
The  ||| S:841 E:845 ||| DT
surprising  ||| S:845 E:856 ||| JJ
discrepancy  ||| S:856 E:868 ||| NN
between  ||| S:868 E:876 ||| IN
the  ||| S:876 E:880 ||| DT
efficacy  ||| S:880 E:889 ||| NN
of  ||| S:889 E:892 ||| IN
antioxidants  ||| S:892 E:905 ||| JJ
in vitro  ||| S:905 E:914 ||| NN
and  ||| S:914 E:918 ||| CC
in  ||| S:918 E:921 ||| IN
animal  ||| S:921 E:928 ||| JJ
models  ||| S:928 E:935 ||| NNS
of  ||| S:935 E:938 ||| IN
atherosclerosis  ||| S:938 E:954 ||| NN
and  ||| S:954 E:958 ||| CC
the  ||| S:958 E:962 ||| DT
lack  ||| S:962 E:967 ||| NN
of  ||| S:967 E:970 ||| IN
protective  ||| S:970 E:981 ||| JJ
effect  ||| S:981 E:988 ||| NN
against  ||| S:988 E:996 ||| IN
cardiovascular  ||| S:996 E:1011 ||| JJ
events  ||| S:1011 E:1018 ||| NNS
and  ||| S:1018 E:1022 ||| CC
death  ||| S:1022 E:1028 ||| NN
in  ||| S:1028 E:1031 ||| IN
epidemiological  ||| S:1031 E:1047 ||| JJ
study  ||| S:1047 E:1053 ||| NN
and  ||| S:1053 E:1057 ||| CC
clinical  ||| S:1057 E:1066 ||| JJ
trials  ||| S:1066 E:1073 ||| NNS
are  ||| S:1073 E:1077 ||| VBP
discussed ||| S:1077 E:1086 ||| VBN
.  ||| S:1086 E:1088 ||| .
In  ||| S:1088 E:1091 ||| IN
contrast ||| S:1091 E:1099 ||| NN
,  ||| S:1099 E:1101 ||| ,
epidemiological  ||| S:1101 E:1117 ||| JJ
studies  ||| S:1117 E:1125 ||| NNS
seem  ||| S:1125 E:1130 ||| VBP
to  ||| S:1130 E:1133 ||| TO
indicate  ||| S:1133 E:1142 ||| VB
that  ||| S:1142 E:1147 ||| IN
the  ||| S:1147 E:1151 ||| DT
Mediterranean  ||| S:1151 E:1165 ||| NNP
diet  ||| S:1165 E:1170 ||| NN
may  ||| S:1170 E:1174 ||| MD
protect  ||| S:1174 E:1182 ||| VB
( ||| S:1182 E:1183 ||| -LRB-
in  ||| S:1183 E:1186 ||| IN
part ||| S:1186 E:1190 ||| NN
)  ||| S:1190 E:1192 ||| -RRB-
against  ||| S:1192 E:1200 ||| IN
atherosclerosis  ||| S:1200 E:1216 ||| JJ
complications  ||| S:1216 E:1230 ||| NNS
( ||| S:1230 E:1231 ||| -LRB-
myocardial  ||| S:1231 E:1242 ||| JJ
infarction  ||| S:1242 E:1253 ||| NN
and  ||| S:1253 E:1257 ||| CC
cardiovascular  ||| S:1257 E:1272 ||| JJ
death ||| S:1272 E:1277 ||| NN
) ||| S:1277 E:1278 ||| -RRB-
.  ||| S:1278 E:1280 ||| .
